Gufic Biosciences receives CRISIL ESG 62 (Strong) rating for FY25-26
Gufic Biosciences Limited received an ESG rating of CRISIL ESG 62 (Strong) for FY25-26 from Crisil ESG Ratings & Analytics. Crisil independently assigned the rating based on publicly available information.
An ESG rating can influence investor perception and potentially impact funding or partnerships, but it's an independent assessment and not a direct company action or financial result.
The company received a 'Strong' ESG rating, which is generally viewed positively by investors and stakeholders.
Gufic Biosciences Limited has been assigned an overall ESG rating of CRISIL ESG 62 (Category: Strong) for the financial year 2025-26. This rating was provided by Crisil ESG Ratings & Analytics Ltd., a SEBI Registered Category – I Environmental, Social and Governance (ESG) Rating Provider, in a report dated September 25, 2026, which the company received on September 28, 2026.
It is important to note that Gufic Biosciences Limited did not engage Crisil for this ESG rating. Crisil independently assigned the rating based on publicly available information pertaining to FY 2025-26.
What to do with a filing like this
Gufic Biosciences Limited filed this with the NSE as a statutory disclosure, categorised under esg reports. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gufic Biosciences Limited. Read the original for the full detail.